Head to Head Contrast: Avita Medical (NASDAQ:RCEL) & CONMED (NYSE:CNMD)

CONMED (NYSE:CNMD – Get Free Report) and Avita Medical (NASDAQ:RCEL – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, dividends, earnings, institutional ownership and risk.

Institutional and Insider Ownership

27.7% of Avita Medical shares are owned by institutional investors. 0.3% of CONMED shares are owned by company insiders. Comparatively, 2.2% of Avita Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Earnings and Valuation

This table compares CONMED and Avita Medical”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
CONMED $1.37 billion 1.10 $47.06 million $2.42 20.92
Avita Medical $71.61 million 6.86 -$48.59 million ($1.18) -13.25

CONMED has higher revenue and earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

CONMED has a beta of 0.9, suggesting that its stock price is 10% less volatile than the S&P 500. Comparatively, Avita Medical has a beta of 2.03, suggesting that its stock price is 103% more volatile than the S&P 500.

Profitability

This table compares CONMED and Avita Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CONMED 5.36% 13.93% 6.26%
Avita Medical -42.65% N/A -71.34%

Analyst Recommendations

This is a breakdown of current ratings for CONMED and Avita Medical, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CONMED 1 7 0 0 1.88
Avita Medical 1 1 5 0 2.57

CONMED presently has a consensus target price of $44.00, indicating a potential downside of 13.10%. Avita Medical has a consensus target price of $16.60, indicating a potential upside of 6.21%. Given Avita Medical’s stronger consensus rating and higher probable upside, analysts plainly believe Avita Medical is more favorable than CONMED.

About CONMED

(Get Free Report)

CONMED Corporation is a medical technology company that develops and markets devices and equipment for orthopedic and general surgery. Its products support minimally invasive procedures and include arthroscopy systems, powered surgical instruments, electrosurgical equipment, and endoscopic technologies. The company was founded in 1970 and serves hospitals, surgery centers, and other healthcare providers. Its products are sold in the United States and internationally.

About Avita Medical

(Get Free Report)

AVITA Medical is a regenerative medicine company focused on treatments for skin restoration. Its flagship technology, the RECELL System, enables clinicians to use a small sample of a patient’s healthy skin to prepare a suspension of skin cells for application to wounds. The company’s RECELL products are used in the treatment of burns and certain other skin injuries, including full-thickness skin defects. The approach is intended to support wound coverage while reducing the amount of donor skin needed compared with conventional skin-grafting procedures.

Receive News & Ratings for CONMED Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CONMED and related companies with MarketBeat.com's FREE daily email newsletter.